{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:08:22Z","timestamp":1767856102885,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001230","name":"Macquarie University","doi-asserted-by":"publisher","award":["MQRIBG 9201501951"],"award-info":[{"award-number":["MQRIBG 9201501951"]}],"id":[{"id":"10.13039\/501100001230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015360","name":"ARC Centre for Nanoscale BioPhotonics","doi-asserted-by":"publisher","award":["CE140100003"],"award-info":[{"award-number":["CE140100003"]}],"id":[{"id":"10.13039\/100015360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["FT150100342"],"award-info":[{"award-number":["FT150100342"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ejps.2019.105038","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T19:45:50Z","timestamp":1565120750000},"page":"105038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Antioxidant properties of probucol released from mesoporous silica"],"prefix":"10.1016","volume":"138","author":[{"given":"Michael","family":"Lau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalpeshkumar","family":"Giri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9097-0179","authenticated-orcid":false,"given":"Alfonso E.","family":"Garcia-Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2019.105038_bb0005","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1021\/cm702440n","article-title":"Hydrothermal phase transformation of bicontinuous cubic mesoporous material AMS-6","volume":"20","author":"Atluri","year":"2008","journal-title":"Chem. Mater."},{"key":"10.1016\/j.ejps.2019.105038_bb0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13098-018-0318-5","article-title":"Antioxidant effects of vitamins in type 2 diabetes: a meta-analysis of randomized controlled trials","volume":"10","author":"Balbi","year":"2018","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.ejps.2019.105038_bb0015","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0022-2275(20)38219-5","article-title":"Concentration-dependent antioxidant activity of probucol in low density lipoproteins in vitro: probucol degradation precedes lipoprotein oxidation","volume":"30","author":"Barnhart","year":"1989","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejps.2019.105038_bb0020","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2337\/diab.40.4.405","article-title":"Role of oxidative stress in development of complications in diabetes","volume":"40","author":"Baynes","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.ejps.2019.105038_bb0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejphar.2006.11.049","article-title":"Oral treatment with probucol in a pharmacological dose has no beneficial effects on mortality in chronic ischemic heart failure after large myocardial infarction in rats","volume":"558","author":"Betge","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2019.105038_bb0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/WOX.0b013e3182439613","article-title":"Oxidative stress and antioxidant defense","volume":"5","author":"Birben","year":"2012","journal-title":"World Allergy Organ. J."},{"key":"10.1016\/j.ejps.2019.105038_bb0035","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1021\/ja01269a023","article-title":"Adsorption of gases in multimolecular layers","volume":"60","author":"Brunauer","year":"1938","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2019.105038_bb0040","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bbrc.2010.04.117","article-title":"Simvastatin lowers reactive oxygen species level by Nrf2 activation via PI3K\/Akt pathway","volume":"396","author":"Chartoumpekis","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejps.2019.105038_bb0045","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1007\/s11064-016-2047-1","article-title":"The antioxidant effects of thymoquinone in activated BV-2 murine microglial cells","volume":"41","author":"Cobourne-Duval","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejps.2019.105038_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067658","article-title":"Probucol increases striatal glutathione peroxidase activity and protects against 3-nitropropionic acid-induced pro-oxidative damage in rats","volume":"8","author":"Colle","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2019.105038_bb0055","doi-asserted-by":"crossref","first-page":"14390","DOI":"10.1021\/acs.jpcc.6b04078","article-title":"Accessing the physical state and molecular mobility of naproxen confined to nanoporous silica matrixes","volume":"120","author":"Cordeiro","year":"2016","journal-title":"J. Phys. Chem. C"},{"key":"10.1016\/j.ejps.2019.105038_bb0060","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1359-6446(04)03139-3","article-title":"Catalytic antioxidants: a radical approach to new therapeutics","volume":"9","author":"Day","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2019.105038_bb0065","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/hy1101.092845","article-title":"Enalapril attenuates oxidative stress in diabetic rats","volume":"38","author":"de Cavanagh","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.ejps.2019.105038_bb0070","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1245049","article-title":"Role of ROS and RNS sources in physiological and pathological conditions","volume":"2016","author":"Di Meo","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.ejps.2019.105038_bb0075","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/BF01195733","article-title":"Structures of two conformational polymorphs of the cholesterol-lowering drug probucol","volume":"23","author":"Gerber","year":"1993","journal-title":"J. Crystallogr. Spectrosc. Res."},{"key":"10.1016\/j.ejps.2019.105038_bb0080","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1387-1811(98)00255-8","article-title":"Novel pathways for the preparation of mesoporous MCM-41 materials: control of porosity and morphology","volume":"27","author":"Gr\u00fcn","year":"1999","journal-title":"Microporous Mesoporous Mater."},{"key":"10.1016\/j.ejps.2019.105038_bb0085","first-page":"193","article-title":"Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease","volume":"70","author":"Holvoet","year":"2008","journal-title":"Verh. K. Acad. Geneeskd. Belg."},{"key":"10.1016\/j.ejps.2019.105038_bb0090","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/0891-5849(96)00177-3","article-title":"Efficacy of lipid soluble, membrane-protective agents against hydrogen peroxide cytotoxicity in cardiac myocytes","volume":"21","author":"Horwitz","year":"1996","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejps.2019.105038_bb0095","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.micromeso.2011.06.001","article-title":"3D cubic mesoporous silica microsphere as a carrier for poorly soluble drug carvedilol","volume":"147","author":"Hu","year":"2012","journal-title":"Microporous Mesoporous Mater."},{"key":"10.1016\/j.ejps.2019.105038_bb0100","doi-asserted-by":"crossref","unstructured":"Jangra, S., Girotra, P., Chhokar, V., Tomer, V., Sharma, A., Duhan, S., 2016. In-vitro drug release kinetics studies of mesoporous SBA-15-azathioprine composite.","DOI":"10.1007\/s10934-016-0123-1"},{"key":"10.1016\/j.ejps.2019.105038_bb0105","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1111\/j.1755-5922.2010.00137.x","article-title":"Natural antioxidants and hypertension: promise and challenges","volume":"28","author":"Kizhakekuttu","year":"2010","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.ejps.2019.105038_bb0110","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1039\/C4TB00418C","article-title":"Influence of microporosity in SBA-15 on the release properties of anticancer drug dasatinib","volume":"2","author":"Kjellman","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ejps.2019.105038_bb0115","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1021\/cm000164e","article-title":"Characterization of the porous structure of SBA-15","volume":"12","author":"Kruk","year":"2000","journal-title":"Chem. Mater."},{"key":"10.1016\/j.ejps.2019.105038_bb0120","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1161\/01.CIR.99.20.2645","article-title":"Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure","volume":"99","author":"Kukin","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ejps.2019.105038_bb0125","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0891-5849(93)90510-2","article-title":"Probucol as an antioxidant and antiatherogenic drug","volume":"14","author":"Kuzuya","year":"1993","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejps.2019.105038_bb0130","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.msec.2017.04.141","article-title":"Improved oral bioavailability of probucol by dry media-milling","volume":"78","author":"Li","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ejps.2019.105038_bb0135","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3164\/jcbn.40.141","article-title":"Antihypertensive and antioxidant action of amlodipine and vitamin C in patients of essential hypertension","volume":"40","author":"Mahajan","year":"2007","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.ejps.2019.105038_bb0140","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1517\/17425247.2015.1111335","article-title":"Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers","volume":"13","author":"Maleki","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2019.105038_bb0145","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jconrel.2017.07.047","article-title":"Mesoporous silica materials: from physico-chemical properties to enhanced dissolution of poorly water-soluble drugs","volume":"262","author":"Maleki","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2019.105038_bb0150","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cej.2007.07.078","article-title":"Studies on MCM-41 mesoporous silica for drug delivery: effect of particle morphology and amine functionalization","volume":"137","author":"Manzano","year":"2008","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.ejps.2019.105038_bb0155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1021\/acs.molpharmaceut.7b00778","article-title":"Role of drug adsorption onto the silica surface in drug release from mesoporous silica systems","volume":"15","author":"McCarthy","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2019.105038_bb0160","article-title":"The role of reactive oxygen species in the pathophysiology of cardiovascular diseases and the clinical significance of myocardial redox","volume":"5","author":"Moris","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ejps.2019.105038_bb0165","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ejpb.2007.12.020","article-title":"Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state","volume":"69","author":"Nielsen","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2019.105038_bb0170","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1056-8727(00)00084-2","article-title":"In vitro and in vivo antioxidant properties of gliclazide","volume":"14","author":"O\u2019Brien","year":"2000","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.ejps.2019.105038_bb0175","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/07315724.2003.10719272","article-title":"Vitamin C as an antioxidant: evaluation of its role in disease prevention","volume":"22","author":"Padayatty","year":"2003","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.ejps.2019.105038_bb0180","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/963520","article-title":"ROS and brain diseases: the good, the bad, and the ugly","volume":"2013","author":"Popa-Wagner","year":"2013","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.ejps.2019.105038_bb0185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1748-1716.2009.02039.x","article-title":"Reactive oxygen and nitrogen species in normal physiological processes","volume":"198","author":"Pourova","year":"2010","journal-title":"Acta Physiol."},{"key":"10.1016\/j.ejps.2019.105038_bb0190","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/09500839408240501","article-title":"Stabilization of the amorphous phase inside carbon nanotubes: solidification in a constrained geometry","volume":"70","author":"Prasad","year":"1994","journal-title":"Philos. Mag. Lett."},{"key":"10.1016\/j.ejps.2019.105038_bb0195","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1021\/la052202k","article-title":"Characterization of micro-mesoporous materials from nitrogen and toluene adsorption:experiment and modeling","volume":"22","author":"Ravikovitch","year":"2006","journal-title":"Langmuir"},{"key":"10.1016\/j.ejps.2019.105038_bb0200","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/01.HYP.0000068370.21009.38","article-title":"Antioxidant activities and oxidative stress byproducts in human hypertension","volume":"41","author":"Red\u00f3n","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ejps.2019.105038_bb0205","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1039\/b804266g","article-title":"Stabilization of the amorphous state of pharmaceuticals in nanopores","volume":"18","author":"Rengarajan","year":"2008","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.ejps.2019.105038_bb0210","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1291\/hypres.30.1159","article-title":"Relationship between oxidative stress and essential hypertension","volume":"30","author":"Rodrigo","year":"2007","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejps.2019.105038_bb0215","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41598-018-36769-3","article-title":"The tri-phasic role of hydrogen peroxide in blood-brain barrier endothelial cells","volume":"9","author":"Shaji","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2019.105038_bb0220","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.dsx.2015.08.016","article-title":"Anti oxidant potential of metformin and pioglitazone in type 2 diabetes mellitus: beyond their anti glycemic effect","volume":"10","author":"Singh","year":"2016","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"10.1016\/j.ejps.2019.105038_bb0225","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3109\/03639045.2011.637051","article-title":"Nanoparticulation of probucol, a poorly water-soluble drug, using a novel wet-milling process to improve in vitro dissolution and in vivo oral absorption","volume":"38","author":"Tanaka","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2019.105038_bb0230","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2174\/092986707780597961","article-title":"Microglial activation and its implications in the brain diseases","volume":"14","author":"Thameem Dheen","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejps.2019.105038_bb0235","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/10837450802244843","article-title":"Characterization and physical stability of spray dried solid dispersions of probucol and PVP-K30","volume":"13","author":"Thybo","year":"2008","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejps.2019.105038_bb0240","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/hq0202.104081","article-title":"Cellular antioxidant effects of atorvastatin in vitro and in vivo","volume":"22","author":"Wassmann","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejps.2019.105038_bb0245","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.taap.2009.06.011","article-title":"Efficient internalization of mesoporous silica particles of different sizes by primary human macrophages without impairment of macrophage clearance of apoptotic or antibody-opsonized target cells","volume":"239","author":"Witasp","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejps.2019.105038_bb0250","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1039\/c3cs35405a","article-title":"Synthesis of mesoporous silica nanoparticles","volume":"42","author":"Wu","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejps.2019.105038_bb0255","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2012.09.008","article-title":"Mesoporous systems for poorly soluble drugs","volume":"453","author":"Xu","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2019.105038_bb0260","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/MOL.0000000000000199","article-title":"Did we abandon probucol too soon?","volume":"26","author":"Yamashita","year":"2015","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.ejps.2019.105038_bb0265","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1007\/s11095-014-1321-7","article-title":"Directed self-assembled nanoparticles of probucol improve oral delivery: fabrication, performance and correlation","volume":"31","author":"Zhang","year":"2014","journal-title":"Pharm. Res."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098719303021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098719303021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:50:10Z","timestamp":1760529010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098719303021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":53,"alternative-id":["S0928098719303021"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2019.105038","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antioxidant properties of probucol released from mesoporous silica","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2019.105038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105038"}}